Valuation: Monogram Technologies Inc.

Market Cap 244M 214M 199M 183M 344M 23.61B 350M 2.38B 929M 11.52B 915M 895M 39.95B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 201M 187M 172M 322M 22.13B 328M 2.23B 871M 10.79B 858M 839M 37.44B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 5.23
Extreme 5.23
6.42
3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
07/10/25 Issuer sale

Director

7,000 0.0172%
07/10/25 Issuer sale

Director

40,000 0.0984%
07/10/25 Issuer sale

Chief Technology Officer

1,312,926 3.2312%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+4.71%-3.23% 244M
+1.52%-4.92%-21.46%+8.32% 119B
-0.04%-3.83%-3.45%-6.91% 12.59B
-1.18%-2.53%+57.77%+107.39% 8.97B
-3.47%+11.33%-43.23%-67.18% 4.84B
-0.59%-9.64%0.00%+38.75% 2.65B
-0.51%-2.30%-8.89%-22.28% 1.64B
+1.24%-5.91%-22.95%-31.52% 1.61B
-2.99%-8.64%-7.42%-59.96% 1.53B
Average -0.87%+0.06%-4.99%-4.07% 16.96B
Weighted average by Cap. +1.00%-1.99%-15.33%+9.57%

Financials

2023 2024
Net sales 0.36 0.32 0.3 0.27 0.51 35.35 0.52 3.57 1.39 17.24 1.37 1.34 59.81 -
Net income -13.75M -12.09M -11.23M -10.33M -19.37M -1.33B -19.72M -134M -52.38M -649M -51.6M -50.49M -2.25B -16.33M -14.36M -13.34M -12.27M -23.01M -1.58B -23.42M -160M -62.22M -771M -61.3M -59.97M -2.68B
Net Debt -13.1M -11.52M -10.7M -9.84M -18.46M -1.27B -18.79M -128M -49.91M -619M -49.17M -48.11M -2.15B -15.33M -13.48M -12.52M -11.52M -21.6M -1.48B -21.99M -150M -58.41M -724M -57.54M -56.29M -2.51B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
27
  1. Stock Market
  2. Stocks
  3. MGRM Stock